Table 8.
Recurrence rates in studies with non-seminomatous GCT patients in cSI managed with surveillance before 1992 and after 1993 [20, 21, 35]
| Reference | N | Therapy | Recurrence rate, % |
|---|---|---|---|
| [35] | 371 (total) | 28.0 | |
| 157 (1988–1992) | lr | 18.7 | |
| hr | 54.5 | ||
| [35] | 214 (1993–2005) | lr | 14.2 |
| hr | 49.2 | ||
| [21] | 1,226 (total) | 30.6 | |
| lr | 12.0 | ||
| hr | 50.0 | ||
| [20] | 1,139 (total) | 19.0 | |
GCT, germ cell tumour; cSI, clinical stage I; hr, high risk; lr, low risk.